Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.2%

3 terminated out of 58 trials

Success Rate

86.4%

-0.1% vs benchmark

Late-Stage Pipeline

9%

5 trials in Phase 3/4

Results Transparency

11%

2 of 19 completed with results

Key Signals

2 with results86% success

Data Visualizations

Phase Distribution

45Total
Not Applicable (14)
P 1 (8)
P 2 (18)
P 3 (4)
P 4 (1)

Trial Status

Completed19
Unknown18
Recruiting12
Not Yet Recruiting3
Terminated3
Active Not Recruiting3

Trial Success Rate

86.4%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (58)

Showing 20 of 20 trials
NCT06085755Phase 1RecruitingPrimary

Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer

NCT03013010Phase 3CompletedPrimary

PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy

NCT07149090Phase 1RecruitingPrimary

Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites

NCT05980416Phase 1TerminatedPrimary

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

NCT05180864Not ApplicableRecruitingPrimary

Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer

NCT07018661Phase 2Recruiting

[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer

NCT06732856Phase 1RecruitingPrimary

A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer

NCT03348150Phase 3Active Not RecruitingPrimary

Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.

NCT03153280Phase 1Terminated

Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer

NCT06028737Phase 2Recruiting

Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer

NCT05782465Active Not RecruitingPrimary

Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)

NCT06923449RecruitingPrimary

Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance

NCT06792149RecruitingPrimary

Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting

NCT06782048Phase 2Not Yet RecruitingPrimary

Use of Pyrvinium to Reverse Stomach Precancerous Conditions

NCT05698992Recruiting

Rehabilitation and Recovery for Persons with Esophageal or Gastric Cancer

NCT02969122Not ApplicableTerminatedPrimary

Treatment Strategy for Stage IV Gastric Cancer with Positive Peritoneal Cytology As the Only Non-curable Factor

NCT06563063Not ApplicableCompletedPrimary

Finding ED90 of Flumazenil for Selective Improvement of Respiratory Distress by Remimazolam

NCT03760822Phase 2Active Not Recruiting

Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients

NCT06435741Not ApplicableUnknownPrimary

Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.

NCT05714878Not ApplicableCompletedPrimary

Multimodal Prehabilitation for Resectable Gastric Cancer

Scroll to load more

Research Network

Activity Timeline